What Legisym does

Legisym, LLC is a privately held SaaS company founded in 2008 and headquartered in Temple, Texas, that builds regulatory compliance technology for the U.S. pharmaceutical supply chain. The company sells three core products on a subscription basis: Express222™, a 100% web-based Controlled Substance Ordering System (CSOS) certified five times by the Drummond Group for DEA Form 222 electronic ordering; License Verify™, an automated federal/state/local pharmaceutical license verification service also Drummond-attested; and Credential Solutions™, a W3C Verifiable Credential issuer for DSCSA 2023 Authorized Trading Partner (ATP) requirements, aligned with Open Credentialing Initiative (OCI) and Partnership for DSCSA Governance (PDG) standards.

The platform is delivered as a web-based SaaS with Service Oriented Architecture (SOA), SHA-1/SHA-2 encryption, and AS2 protocol for EDI 850 controlled substance order exchange. Express222™ is offered with optional add-on toolkits for custom branding, front-end portal integration, back-end ERP integration, and CSOS interoperability, each designed to deepen embedding into customer systems. Supporting services include project management, training (train-the-trainer, one-on-one, webinar), and custom development.

Legisym monetizes exclusively through monthly SaaS subscriptions with no license fees, per-seat fees, annual maintenance fees, or long-term contracts. Go-to-market is sales-led, combining direct enterprise field sales (discovery calls, live demos, custom development sessions) with inside sales, supported by the company website, LinkedIn, Facebook, and thought leadership through OCI and PDG participation. Target customers span pharmaceutical manufacturers, compounders, wholesalers, distributors, 3PLs, repackagers, self-distributing mass retailers, hospitals/health systems, and reverse distributors across the United States.

Name

Legisym

Legal name

Legisym, LLC

Website

https://legisym.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Legisym, founded in 2008 in Temple, Texas, is a private SaaS company providing Drummond Group-certified regulatory compliance solutions — CSOS electronic controlled substance ordering, pharmaceutical license verification, and DSCSA 2023 verifiable credentialing — to U.S. pharmaceutical supply chain participants on a monthly subscription basis.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Compliance Software

NAICS

Custom Computer Programming Services (541511)

SIC

Services-Management Services (8741)

akta.pro primary industry

Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11) (HLAGAKAG)

Keywords

• Pharmaceutical compliance software
• Controlled substance ordering
• License verification services
• DSCSA credentialing solutions
• Pharmaceutical SaaS platform

Headquarters

HQ city

Temple

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS Subscription Revenue: Monthly subscription-based SaaS model for Express222™ CSOS, License Verify™, and Credential Solutions™. Eliminates software license fees, upgrade fees, maintenance contracts, per-seat user fees, and hardware infrastructure costs.
2. Software-as-a-Service (SaaS): All products offered as SaaS solutions with no annual maintenance fees, no per-seat user fees, no long-term contracts, and no hardware or software to purchase. Monthly subscription model.
3. Optional Add-on Toolkits: Custom branding, front-end integration, back-end integration, and CSOS interoperability toolkits available as optional add-ons for Express222™ customers requiring enhanced customization and integration capabilities.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Legisym provides SaaS-based regulatory compliance software for the U.S. pharmaceutical supply chain. Its three core products are Express222™ CSOS (a 100% web-based Controlled Substance Ordering System that replaces paper DEA Form 222), License Verify™ (a federal/state/local pharmaceutical license verification service with API integrations), and Credential Solutions™ (a W3C Verifiable Credential issuance service for DSCSA 2023 Authorized Trading Partner requirements). All products are delivered on a monthly subscription basis with no per-seat, license, or maintenance fees.

Product overview

Legisym provides a portfolio of three SaaS-based regulatory compliance solutions for the pharmaceutical supply chain: Express222™ CSOS (a 100% web-based controlled substance ordering system for DEA Form 222 compliance), License Verify™ (a comprehensive pharmaceutical license verification service across federal, state, and local jurisdictions), and Credential Solutions™ (a verifiable credential issuance service enabling trading partners to prove Authorized Trading Partner status under DSCSA 2023 requirements). All three products are offered in a software-as-a-service model with optional toolkits (Custom Branding, Front-End Integration, Back-End Integration, CSOS Interoperability) available for Express222™. Legisym also provides supporting professional services including project management, training, support, and custom development.

Differentiator

Problem solved

Functional benefit

Brands

• Express222™ CSOS: 100% web-based Controlled Substance Ordering System (CSOS) that enables manufacturers, wholesalers, distributors, health systems, clinics, pharmacies, and other buyers and suppliers to securely sign, validate, and process electronic controlled substance orders with real-time DEA compliance.
• License Verify™
• Credential Solutions™

Products and services

• Express222™ CSOS A 100% Web-based Controlled Substance Ordering System (CSOS) that enables DEA-licensed buyers and suppliers of Schedule II controlled substances to securely sign, validate, and process electronic controlled substance orders with real-time DEA compliance, eliminating paper DEA Form 222.
• License Verify™ A comprehensive service for verifying pharmaceutical licensing across the nation, providing instant verification through a single comprehensive database of federal, state, and local licensing, with optional APIs for integration.
• Credential Solutions™ A verifiable credential issuance service for the pharmaceutical supply chain that enables trading partners to prove their identities and Authorized Trading Partner (ATP) status through W3C Verifiable Credentials, supporting DSCSA 2023 interoperability requirements.
• Project Management Services Certified Project Management Professionals assist clients with project plans, documentation, and toolsets to manage projects from requirement gathering through client/user acceptance using industry best practices.
• Training Services Training offered as Train the Trainer Session, One-on-One User Training, and Webinar Education Development Training, with documentation provided in PDF and editable WordDoc formats for operating procedures and employee onboarding.
• Support Services Email and phone support with a highly trained Support Team using an escalation process to resolve issues. Reports closing over 99% of tickets within the same business day.
• Custom Development Services Custom functionality development for unique business model requirements, including requirements gathering, business case analysis, code development, and testing prior to deployment.

Quantifiable outcome

• 99% of support tickets closed same business day
• +2 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core.

• Open Credentialing Initiative (OCI)coreStrategic or Co-development PartnerOCI Founding Member. Legisym participates in OCI workgroups to standardize credentialing architecture, shepherd governance considerations, help others learn and adopt the architecture, explore other uses for credentials, and contribute to creation and enhancement of documents in an open environment. Legisym's Credential Solutions™ conforms to OCI Conformance Criteria.
• Partnership for DSCSA Governance (PDG)coreStrategic or Co-development PartnerPDG Member. Legisym participates in PDG's collaborative forum dedicated to developing and advancing an effective model for interoperable tracing and verification of prescription pharmaceuticals. Credential Solutions™ aligned with PDG's Foundational Blueprint for 2023 Interoperability.
• Drummond GroupcoreImplementation/ SI/ Consulting PartnerIndependent software review and certification organization trusted to audit Express222™ CSOS on five separate occasions and conduct comprehensive review of License Verify™. Evaluated and documented Legisym's claims related to efficacy, accuracy, and usability.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/legisym
• LinkedInlinkedin.com/company/legisymllc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Legisym